Moderna said it has an ongoing study of its Covid 19 vaccine in adolescents ages 12 to 18 that it launched on Dec . 9 . 
The company discussed the details of the trial at the US Centers for Disease Control and Prevention ’s Advisory Committee on Immunization Practices meeting on Saturday . 
The Moderna vaccine can be used in people who are 18 years and older under the US Food and Drug Administration ’s emergency use authorization . 
Pfizer ’s Covid 19 vaccine is authorized for use in people who are 16 years and older . 
Moderna said it expects the results from its trial in 12 - to 18 year olds sometime in 2021 . 
Moderna said it is also in discussions with the National Institutes of Health about designing an additional pediatric clinical trial in younger subjects , ranging from 6 months of age to 12 years old . 
